Healthcare >> Analyst Interviews >> February 24, 1999

Pharmaceutical Stocks : Steve Plag – Credit Suisse First Boston

JIM KELLY is a Vice President at Credit Suisse First Boston where he follows the major pharmaceutical companies. Previously, he was associated with Lehman Brothers and Anderson Consulting. Mr. Kelly received his Bachelor's degree from Lehigh University and his MBA from Columbia University Graduate School of Business. STEVE PLAG is an Analyst at Credit Suisse First Boston where he follows European pharmaceuticals. Previously, he was associated with NatWest, BZW, Robert Fleming, Salomon Brothers, and Wood MacKenzie. Mr. Plag received his Bachelor's degree in pharmacy from Edinburgh University and is a member of the Royal Pharmaceutical Society. Profile
TWST: Let's start with the climate for investing in pharmaceutical

stocks in 1999. To what would you attribute the decline at the beginning

of the year? Does it reflect the fact that investors are